Executive Director, Global Business Development - Transactions

Join a Legacy of Innovation 110 Years and Counting!

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.

Job Summary

The candidate for Executive Director, Global Business Development – Transactions will possess a strong business acumen with extensive experience in the life sciences and biopharmaceutical industry particularly in the area of Oncology. Expertise and prior experience in the deal making process in the industry as evidenced by a comprehensive deal sheet indicating prior successful deal leadership to closing across the range of counterparties/collaboration partners typically encountered by the Daiichi Sankyo Transactions team is required. The candidate will lead efforts in partnering/licensing for research, development, and commercialization of therapies with a particular focus in Oncology. The candidate is required to have strong interpersonal skills and work with a multitude of internal/external stakeholders to facilitate highly visible and time-sensitive business development projects.

The purpose of this job is to identify, coordinate the assessment of, and help secure pipeline- and portfolio-enhancing, business opportunities (through licensing, acquisition, co-promotion, and other structures.). This role is a primary business development interface with DS Cancer Enterprise, and is responsible for overseeing business development opportunities across a range of categories designed to advance the existing pipeline (including strategic collaborations with pharma partners, companion diagnostic deals, combination studies, ARO collaborations, platform licensing, co-development agreements, divestitures and others) as well as to acquire new product opportunities to augment our pipeline. This role is responsible for interacting with senior leadership within the CE/R&D as well as CEOs, heads of R&D, etc. as well as at companies with whom we are potentially doing a deal. In leading deal teams, this person is responsible for coordinating with commercial, R&D, legal, intellectual property, finance, supply chain, and other relevant functional area colleagues, at all levels, and across geographies, and is required to lead the diligence and assessment process and take lead responsibility for pulling together a recommendation for presentation to senior management. Externally, the job requires initial meetings with potential partners; coordination of capability presentations; coordination of diligence meetings; leading negotiation sessions; and alliance management participation following successful completion of business arrangements. This role also requires one to supervise, train and develop other business development professionals within the Global Business Development function.

Responsibilities

• Execute assigned transactions through proposal/review/negotiation of NBTS and Definitive Agreements, acting as Lead for many opportunities as assigned by the Vice President Global Business Development
• Work in concert with key Functional Area Leads (esp. CE, R&D Finance, R&D (Global Project Team Leader), Business Development, Legal and others) and Senior Management Global Business Development/Daiichi Sankyo Corporate in Tokyo to secure alignment on key terms and conditions prior to and during active negotiations.
• Communicate activities frequently across the organization through related internal approval committees
• Communications should include sharing of key contract related terms and conditions to key stakeholders as well as the related strategic, financial, scientific and commercial rationale for each opportunity reflecting internal analyses as well as diligence activities.
• Respond to Q&A from Finance, Tokyo Business Development, Oncology Business Group, Cancer Enterprise, Corporate Business Management, Senior Management, and other key stakeholders as indicated.
• Meet with other pharmaceutical company licensing groups, participate in industry meetings, conduct proactive product searches, and coordinate search efforts to identify new opportunities to enhance the pipeline as well as in line products.
• Together with colleagues from Search and Evaluation, coordinate with commercial, R&D, finance, supply chain, intellectual property, legal, etc., on both preliminary and full assessments of potential opportunities, and summarize conclusions and recommendations for discussion with and presentation to senior management.
• Schedule and lead diligence meetings with potential partners
• As assigned, provide situational analyses and LCM recommendations to DSI CEO for US product portfolio
• Execute related transactions in support of the US business
• Assure functional excellence by training and development of more junior staff and Direct Report(s).

Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education Qualifications (from an accredited college or university)

MBA or Master's Degree in business related discipline required
Other advanced degree (e.g. JD or MD) preferred

Experience Qualifications

• 10 or More Years experience in life science business development and/or a corporate finance/financial analysis role within the pharmaceutical industry required
• 10 or More Years in leading complex negotiations in a variety of Oncology focused transactions (including multiple major or complex transactions) to closing
• Deal Sheet reflecting breadth of transaction leadership/success required
• Proven ability to manage teams and coach team members’ career development

Travel

Ability to travel up to 30% Frequent overnight travel as required by the deal process; domestic; some global

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.